IPO - Profile


We are a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. We deliver an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Our core capabilities in scientific research and development, our commitment to technical innovation and our engineering excellence are central to our ability to offer value added solutions to our clients.

We have secured a leadership position within the drug More

Offer Price Offer Size 3-Year Outlook Volatility First Day Turnover
$21.00 32,000,000 Positive High 39.17%

Offering Team

  • Legal counsel
  • Skadden, Arps, Slate, Meagher & Flom LLP
  • Auditors
  • Ernst & Young LLP

Deal Highlights

Deal Tracker

IPO Dates

Filing 15 Jul, 2021

Offer 16 Jul, 2021

Look Ahead

Lock Up Expiry Jan 16, 2022

IPO Terms

Offer Price $21.00
Offer Size 32M

Market Sentiments

Stock Price